Context Therapeutics 13G Filing Shows Great Point Partners, LLC Reported A 9.89% Stake In The Co As Of May 31, 2024
Context Therapeutics 13G Filing Shows Great Point Partners, LLC Reported A 9.89% Stake In The Co As Of May 31, 2024
Context Therapeutics的13G申報顯示，Great Point Partners，LLC在2024年5月31日持有公司9.89％的股權。
Context Therapeutics 13G Filing Shows Great Point Partners, LLC Reported A 9.89% Stake In The Co As Of May 31, 2024
Context Therapeutics 13G申報顯示，截至2024年5月31日，Great Point Partners，LLC報告持有公司9.89%的股份。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。